Richard Wagner
Director Ejecutivo en Bonito Biosciences .
Fortuna: - $ al 31/05/2024
Perfil
Richard W.
Wagner was the founder of X-Chem, Inc. (Massachusetts) founded in 2009, Zebiai Therapeutics, Inc. founded in 2019, and Bonito Biosciences founded in 2022, where he held the title of Chief Executive Officer.
He also held the position of Executive Vice President-Discovery Research at Praecis Pharmaceuticals, Inc. and served as an Independent Director at Eterna Therapeutics, Inc. for the year 2023.
Dr. Wagner holds a doctorate degree from Brown University and an undergraduate degree from Trinity College (Connecticut).
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ETERNA THERAPEUTICS INC.
-.--% | 13/07/2023 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Richard Wagner
| Empresas | Cargo | Inicio |
|---|---|---|
| Bonito Biosciences | Director Ejecutivo | 01/06/2022 |
Antiguos cargos conocidos de Richard Wagner.
| Empresas | Cargo | Fin |
|---|---|---|
| ETERNA THERAPEUTICS INC. | Director/Miembro de la Junta | 08/08/2023 |
X-Chem, Inc. (Massachusetts)
 X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Director Ejecutivo | 03/06/2020 |
Zebiai Therapeutics, Inc.
 Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Director Ejecutivo | - |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Director Técnico/Científico/I+D | - |
Formación de Richard Wagner.
| Brown University | Doctorate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Technology Services |
| Bonito Biosciences | |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |
- Bolsa de valores
- Insiders
- Richard Wagner
